Low GI Diet in Children and Adolescents With ALL
Running, not enrolling · Not applicable
Conditions studied: Acute Lymphoblastic Leukemia, Pediatric, Obesity, Pediatric
In brief
The study aims to determine the feasibility of a 6-month low glycemic dietary intervention in children and adolescents undergoing treatment for acute lymphoblastic leukemia.
Key facts
- Study ID
- NCT03157323
- Run by
- Columbia University
- People needed
- 88
- Starts
- 2017-06-01
- Expected to finish
- 2026-09-01
- Last updated by the study team
- 2026-05-29
Who can join
Age: 5 and older, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosis of Acute Lymphoblastic Leukemia (B-Cell, T-Cell, or Mixed Phenotype)
- Within 3 days of starting the induction phase of treatment for Acute Lymphoblastic Leukemia
- Proficient in English or Spanish
You may not qualify if…
- Diagnosis of relapsed Acute Lymphoblastic Leukemia
- Not meeting all of the inclusion criteria
Where it is running
- Connecticut Children's Medical Center — Hartford, Connecticut, United States
- Children's National Hospital — Washington D.C., District of Columbia, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- Columbia University — New York, New York, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.